Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000 - Concepedia

Concepedia

Publication | Open Access

Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000

DOI Full Paper Access

63

Citations

33

References

2016

Year

Prashant Tembhare, Sitaram Ghogale, Nisha Ghatwai, Yajamanam Badrinath, Nikesh Kunder, Nikhil Patkar, Asma Bibi, Gaurav Chatterjee, Brijesh Arora, Gaurav Narula,

Cytometry Part B Clinical Cytometry

Abstract

CD73 and CD86 are the most relevant markers to incorporate in the routine MRD evaluation of BCPALL. © 2016 International Clinical Cytometry Society.

References

	Year	Citations

Page 1